Joseph W. LaPlume, EVP, Corporate Strategy & Develop at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 1,068 shares at $216.36 ($231K) on 2022-11-04, disclosed to the SEC on 2022-11-07.
Open-market sale of $231k CRL by EVP, Corporate Strategy & Develop. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $216.36 | 534 | $116K | 50.0% |
| 2 | $216.36 | 534 | $116K | 50.0% |
| Total | $216.36 avg | 1,068 | $231K | 100% |
| Filing → |
| CRL | SELL | 2025-08-20 | $126K | — | Filing → |
| CRL | SELL | 2025-08-08 | $60K | — | Filing → |
| CRL | SELL | 2025-05-15 | $73K | — | Filing → |